Black Diamond Therapeutics and Ideaya Biosciences are mulling over registrational trials for their lead assets after ...
About 40% of Americans will develop a form of cancer at some point in their lifetime, according to the American Cancer ...
Lung cancer is the leading cause of cancer-related deaths, and the most common form is a non-small-cell type called adenocarcinoma.
essanews.com on MSN5h
Lung cancer warning: Swollen face could be early indicatorLung cancer is one of the most common and aggressive cancers. Its most characteristic symptoms include coughing, shortness of ...
Daily Wrap on MSN6h
Lung cancer warning signs: Facial swelling could indicate diseaseLung cancer is one of the most common and aggressive cancers. Its most characteristic symptoms include coughing, shortness of ...
AstraZeneca's cancer drug, datopotamab deruxtecan, failed to meet targets in a Phase 3 trial, clouding the possibility of approval from the U.S. Food and Drug Administration. Shares were down 1.2% at ...
Amivantamab plus chemo is now indicated in locally advanced or metastatic NSCLC with EGFR exon 19 deletions or exon 21 L858R ...
New research highlights increased stroke, heart attack, and heart failure risks in cancer survivors, especially those treated ...
AstraZeneca said on Monday its experimental precision drug developed with Japan's Daiichi Sankyo did not significantly ...
showing that the ADC could only reduce the risk of death by 6% in patients with locally advanced or metastatic non-squamous ...
A recent study compared two dosages of ifinatamab deruxtecan among patients with extensive-stage small cell lung cancer.
The U.S. is one of only two countries that legally allows drugmakers to advertise products directly to patients. There are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback